期刊名称：International Journal of Health Policy and Management
电子版ISSN：2322-5939
出版年度：2020
卷号：9
期号：10
页码：439-447
DOI：10.15171/ijhpm.2020.01
出版社：Kerman University of Medical Sciences
摘要：Background The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a country with established governance structures and accountable decision-making processes for immunization policy. While the existing literature informs vaccine adoption decisions in GAVI-eligible countries, this study attempts to address a gap in the literature by examining the policy process of a non-GAVI eligible country.
Methods A rotavirus vaccine (RVV) test case was used to compare the decision criteria made by the existing processes (Expanded Program on Immunization [EPI], and National List of Essential Medicines [NLEM]) for vaccine prioritization and the TSE-pilot model, using Thailand specific data.
Results The existing decision-making processes in Thailand and TSE were found to offer similar recommendations on the selection of a RVV product.
Conclusion The authors believe that TSE can provide a well-reasoned and step by step approach for countries, especially low- and middle-income countries (LMICs), to develop a systematic and transparent decision-making process for immunization policy.
